Research Paper Volume 11, Issue 10 pp 2998—3011
Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
Figure 4. Prognostic significance of adjuvant TACE in HCC patients according to Cripto-1 expression. Adjuvant TACE could not increase the OS or TTR times in all HCC patients (A). Kaplan-Meier analysis of the association between adjuvant TACE therapy and OS/TTR in patients with low Cripto-1 expression (B) and high Cripto-1 expression (C).